Outhoff, Kim; Greeff, Oppel Bernhardt Wilhelm
(Oriental Scientific Publishing Company, 2018)
The 15-25% of breast cancers that overexpress human epidermal growth factor receptor type 2 (Her-2) are aggressive and more difficult to treat with conventional chemotherapy than their oestrogen receptor positive (ER+) ...